AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$866M |
| 2 |
Waters Corp
WAT
|
+$434M |
| 3 |
UnitedHealth
UNH
|
+$411M |
| 4 |
Nike
NKE
|
+$351M |
| 5 |
Ferrari
RACE
|
+$295M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$505M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$437M |
| 3 |
NextEra Energy
NEE
|
+$415M |
| 4 |
PayPal
PYPL
|
+$327M |
| 5 |
Procter & Gamble
PG
|
+$300M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.55% |
| 2 | Healthcare | 18.19% |
| 3 | Financials | 12.11% |
| 4 | Consumer Discretionary | 10.55% |
| 5 | Industrials | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Pulmonx
LUNG
$52.8M
| $468K | ﹤0.01% |
41,900
+5,300
| +14% | +$52.3K |
|
|
DM
2602
DELISTED
Desktop Metal, Inc.
DM
| $468K | ﹤0.01% |
20,340
-3,520
| -15% | -$66.4K |
|
|
LAC
2603
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $465K | ﹤0.01% |
21,390
+4,790
| +29% | +$106K |
|
2604
Bristow Group
VTOL
$1.33B
| $464K | ﹤0.01% |
20,732
-3,473
| -14% | -$92.2K |
|
2605
Methanex
MEOH
$4.23B
| $464K | ﹤0.01% |
9,969
+1,200
| +14% | +$56.4K |
|
2606
LendingTree
TREE
$551M
| $463K | ﹤0.01% |
17,381
-4,504
| -21% | -$148K |
|
|
CTIC
2607
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $463K | ﹤0.01% |
110,200
| – | – |
|
2608
ImmunityBio
IBRX
$7.15B
| $458K | ﹤0.01% |
251,558
+25,800
| +11% | +$80.2K |
|
|
ARR
2609
Armour Residential REIT
ARR
$2.32B
| $457K | ﹤0.01% |
17,408
-3,500
| -17% | -$99K |
|
2610
Quanterix
QTRX
$159M
| $453K | ﹤0.01% |
40,200
| – | – |
|
|
PETQ
2611
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $452K | ﹤0.01% |
39,500
+3,000
| +8% | +$33.3K |
|
2612
Kiniksa Pharmaceuticals
KNSA
$6.23B
| $451K | ﹤0.01% |
41,900
| – | – |
|
|
EQRX
2613
DELISTED
EQRx, Inc. Common Stock
EQRX
| $450K | ﹤0.01% |
231,800
| – | – |
|
2614
Capital City Bank Group
CCBG
$897M
| $448K | ﹤0.01% |
15,301
+2,157
| +16% | +$70.1K |
|
2615
BioXcel Therapeutics
BTAI
$24.8M
| $448K | ﹤0.01% |
1,500
| – | – |
|
|
BRSP
2616
BrightSpire Capital
BRSP
$651M
| $448K | ﹤0.01% |
75,901
| – | – |
|
2617
Utah Medical Products
UTMD
$226M
| $445K | ﹤0.01% |
4,700
| – | – |
|
|
CVGW
2618
DELISTED
Calavo Growers
CVGW
| $441K | ﹤0.01% |
15,330
-3,717
| -20% | -$111K |
|
2619
Evolus
EOLS
$397M
| $438K | ﹤0.01% |
51,800
| – | – |
|
|
ADN
2620
DELISTED
Advent Technologies
ADN
| $437K | ﹤0.01% |
13,742
+468
| +4% | +$23.6K |
|
2621
Camden National
CAC
$988M
| $437K | ﹤0.01% |
12,066
| – | – |
|
2622
IDEAYA Biosciences
IDYA
$3.43B
| $437K | ﹤0.01% |
31,800
+5,100
| +19% | +$85K |
|
2623
Gevo
GEVO
$353M
| $436K | ﹤0.01% |
283,300
+4,700
| +2% | +$8.9K |
|
2624
MiMedx Group
MDXG
$630M
| $436K | ﹤0.01% |
127,900
| – | – |
|
2625
Portillo's
PTLO
$345M
| $436K | ﹤0.01% |
20,400
| – | – |
|
Similar funds
AllianceBernstein's Q1 2023 Portfolio in Review
As of Q1 2023, AllianceBernstein held 3,311 positions worth $233B, up 5% from $222B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
AllianceBernstein's Q1 2023 filing shows 51 new, 837 increased, 1,831 reduced and 136 closed positions. Its largest new stake was GE HealthCare: 474,412 shares worth $38.9M. The largest sale was Home Depot, an estimated $505M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q1 2023 buy was GE HealthCare: 474,412 shares worth $38.9M.
- AllianceBernstein added most to Eli Lilly in Q1 2023, an estimated $866M increase.
- AllianceBernstein's biggest Q1 2023 reduction was Home Depot, cutting an estimated $505M.
- AllianceBernstein fully exited SVB Financial Group in Q1 2023, selling an estimated $144M.
- AllianceBernstein's ten largest holdings make up 23% of its $233B portfolio in Q1 2023.
- AllianceBernstein opened 51 new positions and closed 136 in Q1 2023.
- AllianceBernstein's portfolio value rose 5% quarter-over-quarter to $233B.
Based on AllianceBernstein's 13F filing for Q1 2023, filed 15 May 2023.